Ezra Cohen, MD of the University of California at San Diego discusses new agents in clinical trials that appear interesting and potentially valuable additions to the therapeutic armamentarium for SCCHN at ASTRO Head and Neck Symposium 2016.
Ezra Cohen, MD of the University of California at San Diego discusses new agents in clinical trials that appear interesting and potentially valuable additions to the therapeutic armamentarium for SCCHN at ASTRO Head and Neck Symposium 2016.